Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Acidaminococcus - : Slow digestible carbohydrates. {Low Glycemic} |
👶
Human gut bacterial communities are altered by addition of cruciferous vegetables to a controlled fruit- and vegetable-free diet. The Journal of nutrition (J Nutr ) Vol: 139 Issue 9 Pages: 1685-91 Pub: 2009 Sep Epub: 2009 Jul 29 Authors Li F , Hullar MA , Schwarz Y , Lampe JW , Html Article Publication |
| Increases Acidaminococcus - : Slow digestible carbohydrates. {Low Glycemic} |
👪
Positive Synergistic Effects of Quercetin and Rice Bran on Human Gut Microbiota Reduces Enterobacteriaceae Family Abundance and Elevates Propionate in a Bioreactor Model. Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue Pages: 751225 Pub: 2021 Epub: 2021 Sep 30 Authors Ghimire S , Wongkuna S , Sankaranarayanan R , Ryan EP , Bhat GJ , Scaria J , Publication |
| Decreases Acidaminococcus - : Slow digestible carbohydrates. {Low Glycemic} |
👶
A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota. Food & function (Food Funct ) Vol: 8 Issue 12 Pages: 4644-4656 Pub: 2017 Dec 13 Epub: Authors Zhao L , Zhang Q , Ma W , Tian F , Shen H , Zhou M , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
